Krier Michael, Ahmed Aijaz
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite # 210, Stanford, CA 94304, USA.
Clin Liver Dis. 2009 May;13(2):167-77. doi: 10.1016/j.cld.2009.02.001.
Traditionally, the constellation of biochemistry tests including liver enzymes, total bilirubin, and hepatic synthetic measures (prothrombin time (PT) and serum albumin level) are referred to as liver function tests (LFTs). Abnormal LFTs can be encountered during primary health care visits, routine blood donation, and insurance screening. A reported 1% to 4% of asymptomatic patients exhibit abnormal LFTs, leading to a sizeable number of annual consultations to a gastroenterology and/or hepatology practice. A cost-effective and systematic approach is essential to the interpretation of abnormal LFTs. A review of pattern of abnormal LFTs, detailed medical history, and a comprehensive physical examination help establish a foundation for further individualized testing. Further investigation often involves biochemical testing for disease-specific markers, radiographic imaging, and even consideration of a liver biopsy. In the following account, markers of hepatic injury are reviewed followed by a discussion on an approach to various patterns of abnormal LFTs in an asymptomatic patient.
传统上,包括肝酶、总胆红素以及肝脏合成指标(凝血酶原时间(PT)和血清白蛋白水平)在内的一系列生化检查被称为肝功能检查(LFTs)。在初级卫生保健就诊、常规献血和保险筛查过程中,都可能出现肝功能检查异常的情况。据报道,1%至4%的无症状患者肝功能检查结果异常,这导致每年有大量患者向胃肠病学和/或肝病学科室咨询。对于肝功能检查异常结果的解读,采用一种经济高效且系统的方法至关重要。对肝功能检查异常模式、详细病史以及全面体格检查进行回顾,有助于为进一步的个体化检查奠定基础。进一步的检查通常包括针对疾病特异性标志物的生化检测、影像学检查,甚至还要考虑进行肝活检。在以下内容中,将先对肝损伤标志物进行回顾,然后讨论针对无症状患者各种肝功能检查异常模式的处理方法。